Narsico, Joana Marie B.

HRN: 24-58-02  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/16/2024
CO-AMOXICLAV 625MG (TAB)
02/16/2024
02/23/2024
PO
625mg
BID
Thinly MSAF; RMLE And Repair
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: